Main menu

NEW YORK (GenomeWeb News) – Iffmedic will market and sell Multiplicom's molecular diagnostic kits in Central Europe under a deal announced by the companies today.

Under the terms of the deal, the companies will co-promote Multiplicom's products, close sales agreements, and provide support to customers in Germany, Austria, and Eastern Europe. Multiplicom had already been selling its products in Germany.

This webinar will walk through key considerations and helpful guidelines to accelerate next-generation sequencing (NGS)-based clinical genomics assay validation for less money and greater confidence in results.

This webinar will discuss an optimized protocol for methyl-CpG binding domain sequencing (MBD-seq), which enables comprehensive, adequately powered, and cost-effective large-scale methylome-wide association studies (MWAS) of almost all 28 million CpG sites in the genome.